These include Angiotensin 1-converting enzyme gene (ACE), which has been shown to have possible mitogenic and angiogenic effects in cell line and animal models of breast cancer [13], and heparanase (HPR), which has been proposed as a target for the development of breast cancer directed gene therapy [16]. The gene discussed is ACE; the disease is breast carcinoma.